TRAIL signaling is understood to be anti-inflammatory and protective in atherosclerosis, as demonstrated by suppressed circulating levels of TRAIL in CAD [6,7,8,9,10], with preclinical studies supporting a vascular protective role [7,11,12]. This evidence concerns the gene TNFSF10 and atherosclerosis.